Stocktoria
CareDx, Inc. CDNA
CareDx, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $379.8M | $333.8M | $280.3M | $321.8M | $296.4M | $192.2M | $127.1M | $76.6M | $48.3M | $40.6M |
| Gross profit | — | — | — | — | — | — | $81.6M | $43.6M | $27.0M | — |
| R&D expense | $71.4M | $72.5M | $82.4M | $90.4M | $76.5M | $48.9M | $30.7M | $14.5M | $12.4M | $12.4M |
| Operating income | -$30.8M | $40.8M | -$203.4M | -$77.2M | -$29.7M | -$22.5M | -$24.5M | -$15.6M | -$20.3M | -$37.3M |
| Income tax | $271,000 | $310,000 | $141,000 | $379,000 | -$1.4M | -$1.0M | -$2.0M | -$1.4M | -$1.7M | -$1.6M |
| Net income | -$21.4M | $52.5M | -$190.3M | -$76.6M | -$30.7M | -$18.7M | -$22.0M | -$46.8M | -$55.5M | -$39.5M |
| EPS (diluted) | $-0.40 | $0.93 | $-3.54 | $-1.44 | $-0.59 | $-0.40 | $-0.52 | $-1.31 | $-2.38 | $-2.39 |
| Operating cash flow | $42.0M | $38.0M | -$18.4M | -$25.2M | -$19.3M | $33.4M | -$2.8M | -$4.0M | -$14.3M | -$16.5M |
| Free cash flow | — | — | — | — | — | — | — | -$6.0M | -$14.5M | -$17.1M |
| Cash & equivalents | $65.4M | $114.7M | $82.2M | $89.9M | $348.5M | $134.7M | $38.2M | $64.6M | $16.9M | $17.3M |
| Inventory | $26.7M | $19.5M | $19.5M | $19.2M | $17.2M | $10.0M | $6.0M | $4.9M | $5.5M | $5.5M |
| Total assets | $413.2M | $491.1M | $466.8M | $543.0M | $566.6M | $368.5M | $151.7M | $130.7M | $83.6M | $76.7M |
| Total liabilities | $110.1M | $112.6M | $205.5M | $112.1M | $100.7M | $90.8M | $52.7M | $34.8M | $89.5M | $57.0M |
| Shareholders' equity | $303.1M | $378.4M | $261.3M | $430.9M | $465.9M | $277.7M | $99.0M | $95.9M | -$6.1M | $19.8M |
Growth · year-over-year · Revenue CAGR 28.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +13.8% | +19.1% | -12.9% | +8.6% | +54.2% | +51.3% | +66.0% | +58.4% | +18.9% | +44.4% |
| Net income growth | -140.6% | — | — | — | — | — | — | — | — | — |
| EPS growth | -143.0% | — | — | — | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.